Click here for slides on this topic


Platelet

A blood particle involved in coagulation and the maintenance of hemostasis.


The following content matched the glossary term: Platelet

Outcome of Acute ST-Segment Elevation Myocardial Infarction in Diabetics Treated w Fibrinolytic or Combination Reduced Fibrinolytic Therapy & Glycoprotein

Top

Gurm HS, MD, Lincoff AM, MD, Lee D, MD, et al. Outcome of Acute ST-Segment Elevation Myocardial Infarction in Diabetics Treated With Fibrinolytic or Combination Reduced Fibrinolytic Therapy and Platelet Glycoprotein IIb/IIIa Inhibition. Lessons From the GUSTO V Trial. J Am Coll Cardiol. 2004;43:542-548. We studied the outcome of diabetics enrolled in the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) V trial to assess whether the combination of half-dose reteplase and abciximab provides any propitious benefits over standard fibrinolytic therapy in diabetic patients.

Pioglitazone in Type 2 Diabetes Poorly Controlled With a-Glucosidase Inhibitors, Alone or in Combination With Sulfonylureas

Top

Hayashi Y, Miyachi N, Takeuchi T, et al. Clinical evaluation of pioglitazone in patients with type 2 diabetes using a-glucosidase inhibitor and examination of its efficacy profile. Diabetes Obes Metab. 2003;5:58-65. Twenty patients with type 2 diabetes poorly controlled with a-glucosidase inhibitors, alone or in combination with a sulfonylurea, were enrolled in a 16-week, open-label study to receive 30 mg pioglitazone, orally, once a day in addition to their current medications.

The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly

Top

Barzilay JI, Abraham L, Heckbert SR, et al. The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly. Diabetes. 2001;50:2384-2389. Several studies suggest that inflammation plays a role in the pathogenesis of some glucose disorders in adults. We tested this hypothesis in a longitudinal cohort study of older individuals who had normal fasting glucose (FG) values at baseline.

Diabetes Accelerates Smooth Muscle Accumulation in Lesions of Atherosclerosis: Lack of Direct Growth-Promoting Effects of High Glucose Levels

Top

Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: Lack of direct growth-promoting effects of high glucose levels. Diabetes. 2001;50:851-860. In combination with other factors, hyperglycemia may cause the accelerated progression of atherosclerosis in people with diabetes. Arterial smooth muscle cell (SMC) proliferation and accumulation contribute to formation of advanced atherosclerotic lesions.

Cardiovascular Disease in the Diabetic Woman

Top

Kaseta JR, Skafar DF, Ram JL, Jacober SJ, Sowers JR. Cardiovascular Disease in the Diabetic Woman. J Clin Endocrinol Metab. 1999.84:1835-1838. The incidence of cardiovascular disease (CVD) with age is increasing in the United States, and elderly women constitute a disproportional component of the aging population. Elderly women also have a relatively high incidence of diabetes, which contributes to this relatively high CVD risk.



Slide Library Results

Search Results for: Platelet Slides Found: 12
PPARg Exerts Antiatherogenic Effects via Multiple Vascular Targets (animated)
POPADAD Trial: Effect of Antioxidant Use on Events in Patients With Diabetes
Platelet Inhibition During Percutaneous Coronary Intervention
CHAMPION PHOENIX: Randomization
CHAMPION PHOENIX: Ischemic Endpoints
CHAMPION PHOENIX: Baseline Characteristics
CHAMPION PHOENIX: Rate of the Primary Efficacy Endpoint
CHAMPION PHOENIX: Rate of the Primary Efficacy Endpoint at 30 Days
CHAMPION PHOENIX: Rate of the Key Secondary Efficacy Endpoint
CHAMPION PHOENIX: Rate of the Primary Safety Endpoint
CHAMPION PHOENIX: Rate of Intraprocedural Stent Thrombosis
CHAMPION PHOENIX: Rate of Adverse Events